Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

31.580
+0.5201.67%
Volume:11.20M
Turnover:351.38M
Market Cap:191.50B
PE:29.10
High:31.880
Open:31.100
Low:30.760
Close:31.060
52wk High:43.939
52wk Low:27.882
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:0.87
T/O Rate:0.18%
Dividend:0.43
Dividend Rate:1.37%
EPS(LYR):1.085
ROE:17.35%
ROA:9.44%
PB:4.64
PE(LYR):29.10
PS:10.92

Loading ...

Earning Preview: HANSOH PHARMA revenue expected to grow with resilient margins, institutions tilt positive

Earnings Agent
·
Aug 19

Hansoh Pharmaceutical Group Stock Advances 1.7% in Hong Kong

Dow Jones
·
Yesterday

Hansoh Pharmaceutical Group Stock Slides 6.1% in Hong Kong

Dow Jones
·
Aug 24

Movement Alert|HANSOH PHARMA Declines 3.26% in Regular Trading, Trading at HK$32.06

Market Focus
·
Aug 24

Hansoh Pharmaceutical Group Stock Sheds 1.8% in Hong Kong

Dow Jones
·
Aug 21

Movement Alert|HANSOH PHARMA Falls 3.09% in Regular Trading, Pharmaceutical Sector Broadly Weak

Market Focus
·
Aug 21

Hansoh Pharmaceutical Group Stock Rises 2.1% in Hong Kong

Dow Jones
·
Aug 20

Movement Alert|HANSOH PHARMA Rises 3.34% in Regular Trading, Broker Upgrades Target Price Ahead of Interim Results

Market Focus
·
Aug 20

Hansoh Pharmaceutical Group Stock Sheds 1.1% in Hong Kong

Dow Jones
·
Aug 17

Hansoh Pharmaceutical Group Stock Rises 1.1% in Hong Kong

Dow Jones
·
Aug 13

Movement Alert|HANSOH PHARMA Rises 3.94% in Regular Trading, Pharma Sector Rebounds as Pipeline Catalysts Accumulate

Market Focus
·
Aug 13

Hansoh Pharmaceutical Group Stock Falls 3.8% in Hong Kong

Dow Jones
·
Aug 12

Movement Alert|HANSOH PHARMA Falls 3.16% in Regular Trading, Pharmaceutical Sector Broadly Weakens

Market Focus
·
Aug 12

Movement Alert|HANSOH PHARMA Rises 3.47% in Regular Trading, New Drug Clinical Approval and Pipeline Milestones Continue to Drive Momentum

Market Focus
·
Aug 11

Hansoh Pharmaceutical Group Stock Climbs 4.9% in Hong Kong

Dow Jones
·
Aug 10

Movement Alert|HANSOH PHARMA Rises 3.65% in Regular Trading, New Drug Clinical Approval and Pipeline Milestones Drive Momentum

Market Focus
·
Aug 10

Hansoh Pharmaceutical Group Stock Rises 3.9% in Hong Kong

Dow Jones
·
Aug 07

Movement Alert|HANSOH PHARMA Rises 3.6% in Regular Trading, New Drug HS-10582 Receives NMPA Clinical Trial Approval

Market Focus
·
Aug 07

Hansoh Pharma Receives NMPA Clearance for HS-10582 Phase I Clinical Trials in Hypercholesterolemia

Bulletin Express
·
Aug 06

HANSOH PHARMA Receives Clinical Trial Approval for HS-10582 Tablets

Stock News
·
Aug 06